Hollsteen
← Cadence

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 2016: $810M · 10-Q 0000813672-16-000045 filed Apr 25, 2016Cash and equivalents · Q2 2016: $670M · 10-Q 0000813672-16-000050 filed Jul 25, 2016Cash and equivalents · Q3 2016: $524M · 10-Q 0000813672-16-000056 filed Oct 24, 2016Cash and equivalents · Q4 2016: $465M · 10-K 0000813672-17-000006 filed Feb 10, 2017Cash and equivalents · Q1 2017: $544M · 10-Q 0000813672-17-000011 filed Apr 25, 2017Cash and equivalents · Q2 2017: $656M · 10-Q 0000813672-17-000017 filed Jul 24, 2017Cash and equivalents · Q3 2017: $678M · 10-Q 0000813672-17-000023 filed Oct 26, 2017Cash and equivalents · Q4 2017: $688M · 10-K 0000813672-18-000008 filed Feb 20, 2018Cash and equivalents · Q1 2018: $747M · 10-Q 0000813672-18-000014 filed Apr 25, 2018Cash and equivalents · Q2 2018: $820M · 10-Q 0000813672-18-000020 filed Jul 23, 2018Cash and equivalents · Q3 2018: $545M · 10-Q 0000813672-18-000025 filed Oct 22, 2018Cash and equivalents · Q4 2018: $533M · 10-K 0000813672-19-000008 filed Feb 27, 2019Cash and equivalents · Q1 2019: $539M · 10-Q 0000813672-19-000014 filed Apr 22, 2019Cash and equivalents · Q2 2019: $633M · 10-Q 0000813672-19-000022 filed Jul 22, 2019Cash and equivalents · Q3 2019: $655M · 10-Q 0000813672-19-000027 filed Oct 21, 2019Cash and equivalents · Q4 2019: $705M · 10-K 0000813672-20-000007 filed Feb 24, 2020Cash and equivalents · Q1 2020: $946M · 10-Q 0000813672-20-000013 filed Apr 20, 2020Cash and equivalents · Q2 2020: $1.2B · 10-Q 0000813672-20-000020 filed Jul 20, 2020Cash and equivalents · Q3 2020: $1.3B · 10-Q 0000813672-20-000027 filed Oct 19, 2020Cash and equivalents · Q4 2020: $928M · 10-K 0000813672-21-000009 filed Feb 22, 2021Cash and equivalents · Q1 2021: $743M · 10-Q 0000813672-21-000016 filed Apr 26, 2021Cash and equivalents · Q2 2021: $847M · 10-Q 0000813672-21-000028 filed Jul 26, 2021Cash and equivalents · Q3 2021: $1.0B · 10-Q 0000813672-21-000037 filed Oct 25, 2021Cash and equivalents · Q4 2021: $1.1B · 10-K 0000813672-22-000012 filed Feb 22, 2022Cash and equivalents · Q1 2022: $1.1B · 10-Q 0000813672-22-000022 filed Apr 25, 2022Cash and equivalents · Q2 2022: $1.0B · 10-Q 0000813672-22-000037 filed Jul 25, 2022Cash and equivalents · Q3 2022: $1.0B · 10-Q 0000813672-22-000054 filed Oct 24, 2022Cash and equivalents · Q4 2022: $882M · 10-K 0000813672-23-000011 filed Feb 13, 2023Cash and equivalents · Q1 2023: $917M · 10-Q 0000813672-23-000025 filed Apr 24, 2023Cash and equivalents · Q2 2023: $874M · 10-Q 0000813672-23-000041 filed Jul 24, 2023Cash and equivalents · Q3 2023: $962M · 10-Q 0000813672-23-000068 filed Oct 23, 2023Cash and equivalents · Q4 2023: $1.0B · 10-K 0000813672-24-000034 filed Feb 14, 2024Cash and equivalents · Q1 2024: $1.0B · 10-Q 0000813672-24-000092 filed Apr 24, 2024Cash and equivalents · Q2 2024: $1.1B · 10-Q 0000813672-24-000155 filed Jul 24, 2024Cash and equivalents · Q3 2024: $2.8B · 10-Q 0000813672-24-000192 filed Oct 30, 2024Cash and equivalents · Q4 2024: $2.6B · 10-K 0000813672-25-000024 filed Feb 21, 2025Cash and equivalents · Q1 2025: $2.8B · 10-Q 0000813672-25-000051 filed Apr 30, 2025Cash and equivalents · Q2 2025: $2.8B · 10-Q 0000813672-25-000113 filed Jul 30, 2025Cash and equivalents · Q3 2025: $2.8B · 10-Q 0000813672-25-000148 filed Oct 29, 2025Cash and equivalents · Q4 2025: $3.0B · 10-K 0000813672-26-000016 filed Feb 19, 2026Cash and equivalents · Q1 2026: $1.4B · 10-Q 0000813672-26-000047 filed May 1, 20268101,4073,001Q1 2016Q1 2026Q1 2021
$MCash and equivalents · Q1 2016: $810M · 10-Q 0000813672-16-000045 filed Apr 25, 2016Cash and equivalents · Q2 2016: $670M · 10-Q 0000813672-16-000050 filed Jul 25, 2016Cash and equivalents · Q3 2016: $524M · 10-Q 0000813672-16-000056 filed Oct 24, 2016Cash and equivalents · Q4 2016: $465M · 10-K 0000813672-17-000006 filed Feb 10, 2017Cash and equivalents · Q1 2017: $544M · 10-Q 0000813672-17-000011 filed Apr 25, 2017Cash and equivalents · Q2 2017: $656M · 10-Q 0000813672-17-000017 filed Jul 24, 2017Cash and equivalents · Q3 2017: $678M · 10-Q 0000813672-17-000023 filed Oct 26, 2017Cash and equivalents · Q4 2017: $688M · 10-K 0000813672-18-000008 filed Feb 20, 2018810688Q1 2016Q4 2017Q1 2017
Q1 2016
810$M
All values (41)
PeriodValue ($M)Status
Q1 20261,407reported
Q4 20253,001reported
Q3 20252,753reported
Q2 20252,823reported
Q1 20252,778reported
Q4 20242,644reported
Q3 20242,786reported
Q2 20241,059reported
Q1 20241,012reported
Q4 20231,008reported
Q3 2023962reported
Q2 2023874reported
Q1 2023917reported
Q4 2022882reported
Q3 20221,026reported
Q2 20221,030reported
Q1 20221,135reported
Q4 20211,089reported
Q3 20211,014reported
Q2 2021847reported
Q1 2021743reported
Q4 2020928reported
Q3 20201,307reported
Q2 20201,189reported
Q1 2020946reported
Q4 2019705reported
Q3 2019655reported
Q2 2019633reported
Q1 2019539reported
Q4 2018533reported
Q3 2018545reported
Q2 2018820reported
Q1 2018747reported
Q4 2017688reported
Q3 2017678reported
Q2 2017656reported
Q1 2017544reported
Q4 2016465reported
Q3 2016524reported
Q2 2016670reported
Q1 2016810reported

CSV with all sources · Technical ID: cash

More metrics for Cadence

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$810M
Period
Q1 2016, ended Apr 2, 2016 · as of Apr 2, 2016 (balance as of date, not a sum)
Source
10-Q, filed Apr 25, 2016 · 0000813672-16-000045
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$810MApr 25, 201610-Q 0000813672-16-000045reported · confidence 1. · current